New Tablet Coating Product by Ideal Cures, In Geneva

Ideal Cures, Indian pharmaceutical company at the Vitafoods Europe event in Geneva on Tuesday, will launch Instanute DR, a coating product for solid oral medicines.

"Instanute DR is a path-breaking product for delaying the release of the active ingredients having wide applicability in nutraceutical, food and dietary supplement industry," Suresh Pareek, managing director and one of the inventors of the product, said in a statement.

How to Select Over-the-Counter (OTC) Drugs for Allergy
Over-the-counter (OTC) drugs can be bought without a prescription. OTC allergy medications are for the allergy sufferer to choose the right over-the-counter drugs.

"Instanute DR is ready to use enteric coating product and will help in maintaining efficacy of the active ingredient which are sensitive to high acidic pH in stomach," he added.

Instanute DR is a film that is applied by a coating process to postpone the release of active ingredients in the intestine.

Through its use, scientists will be able to programme the release profile of the active ingredients ranging from 20 to 120 minutes. This is the first time Alginic Acid- based composition has been developed to delay the release of drugs by film coating.

Diabetics Could Be Helped by Oral Medicines as Well
People with type 2 diabetes may soon be able to lead an insulin free life, for a new study has revealed that oral medications may be enough for controlling the disease.

Ideal Cures is the world's leading manufacturer and exporter of pharmaceutical excipients, acrylic polymers and ready-to-use coating systems for solid oral dosage forms. It has three manufacturing plants located at Vasai, Jammu and Khambhat along with two modern research and development facilities at Mumbai and Vasai.

Source-IANS

Oral Medicine Found To Remove Excess Iron in the Body
People suffering from severe chronic anemias and those with beta-thalassemia need frequent blood transfusions to remain healthy.

US Patent for Pharma Coating Technology Granted to Ideal Cures
A US patent for an innovation, claimed as both cost-effective and non-toxic has been secured by Ideal Cures, a company specializing in film coating compositions on tablets.